Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
5/1/2024
BIO Survey Investigates US Biopharma's Dependence on Chinese CDMOs Ami...
4/29/2024
WuXi Wants to Regain Client Confidence Amid Claims of IP Transfer to C...
4/11/2024
Drugmakers Race to Find Alternative Suppliers as US Cracks Down on Chi...
4/8/2024
Boehringer Ingelheim and Sino Biopharm Enter Strategic Deal to Develop...
4/2/2024
Aurisco Launches State-of-the-Art Manufacturing Facility for GLP-1 Pep...
3/29/2024
WuXi AppTec Shared US Client's Data with Beijing (Reuters)
3/29/2024
Small Biotechs Reveal Reliance on Chinese CDMOs (BioCentury)
3/27/2024
U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies (WSJ...
3/27/2024
BIOSECURE Act May Implicate WuXi-Produced Drugs in the US Market
3/26/2024
Anti-China Bills Portend Massive Blow to Biotech: BioCentury Survey (B...
3/20/2024
China Ranked Top Potential Biopharma Outsourcing Destination (Bioproce...
3/20/2024
WuXi Biologics Breaks Ground on State-of-the-Art $1.4 Billion CRDMO Fa...
3/20/2024
WuXi XDC Builds Singapore Manufacturing Facility for Global Bioconjuga...
3/18/2024
The US and Chinese Biopharma Contractors (Science)
2/16/2024
Anti-China Biotech Policy: Biosecure & Beyond (BioCentury Video)
2/5/2024
U.S. Congress Postpones Legislation Targeting Chinese Biotech Firms
1/29/2024
Lonza to Close Biologics Plant in Guangzhou after Only Three Years of ...
1/29/2024
Proposed US Legislation Rattles Chinese Biopharma Cos amid National Se...
1/25/2024
Celltrion, China's WuXi Bolster Ties on ADC Partnership
1/23/2024
Jiuzhou Pharma to Build $42M Drug R&D Platform in Japan for Foreign Cl...
1/11/2024
WuXi Biologics Announces Research Service Agreement with BioNTech on N...
1/10/2024
WuXi Biologics Expands Manufacturing Capacity in the US
1/6/2024
Boehringer Ingelheim partners with Ribo to develop new treatments for ...
12/25/2023
Oncoshot Teams Up with Zhejiang Ablaze Medicine to Drive Data-Powered ...
12/10/2023
WuXi Biologics Successfully Implemented a Fully Integrated Continuous ...
11/13/2023
Boehringer Ingelheim and ChromX Health Join Hands to Research Lung Dis...
11/7/2023
WuXi XDC Eyes Up to $471M in Hong Kong IPO
11/1/2023
Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma
10/17/2023
China: The New Frontier for Western CDMOs? (Contract Pharma)
9/28/2023
Chime Biologics Enters Strategic Deal with Kings Pharm to Accelerate B...
Page:
2
/
19
Total number of articles:
545
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit